Articles tagged with “regulation”
President Trump's 2026 executive order on psychedelic research signals a regulatory shift that could affect compounded ketamine troche access and prescribing.
Compounded ketamine troches are not FDA-approved but are legal under 503A compounding law. Understand prescriber liability, regulatory status, and what this means for patients.
Send corrections, provider questions, or advertising inquiries.
